CHINOOK THERAPEUTICS, INC. (KDNY) is a publicly traded company in the Unknown sector. Across all available filings, 14 corporate insiders have executed 182 transactions totaling $104.7M, demonstrating a bearish sentiment with -$48.6M in net insider flow. The most recent transaction on Aug 11, 2023 involved a transaction of 3,300 shares valued at $0.
No significant insider buying has been recorded for KDNY in the recent period.
No significant insider selling has been recorded for KDNY in the recent period.
Based on recent SEC filings, insider sentiment for KDNY is bearish with an Insider Alignment Score of 27/100 and a net flow of -$48.6M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
Insider trading at CHINOOK THERAPEUTICS, INC. (KDNY) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 14 insiders are actively trading KDNY stock, having executed 182 transactions in the past 90 days. The most active insider is Davis Jerel (Executive), who has made 49 transactions totaling $43.1M.
Get notified when executives and directors at KDNY file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Aug 11, 2023 | Akkaraju Srinivas | Executive | Disposition | 3,300 | $N/A | $0 | |
| Aug 11, 2023 | Akkaraju Srinivas | Executive | Disposition | 5,161,888 | $N/A | $0 | |
| Aug 11, 2023 | Bjerkholt Eric | Executive | Disposition | 39,371 | $N/A | $0 | |
| Aug 11, 2023 | Jerel Davis | Executive | Disposition | 719,104 | $N/A | $0 | |
| Aug 11, 2023 | Jerel Davis | Executive | Disposition | 447,013 | $N/A | $0 | |
| Aug 11, 2023 | Jerel Davis | Executive | Disposition | 2,105,107 | $N/A | $0 | |
| Aug 11, 2023 | Jerel Davis | Executive | Disposition | 210,996 | $N/A | $0 | |
| Aug 11, 2023 | Dobmeier Eric | Executive | Disposition | 301,138 | $N/A | $0 | |
| Aug 11, 2023 | Frohlich Tom | Executive | Disposition | 150,777 | $N/A | $0 | |
| Aug 11, 2023 | Mariner Greenman William | Executive | Disposition | 23,643 | $N/A | $0 | |
| Aug 11, 2023 | Renee Griffin Michelle | Executive | Disposition | 3,300 | $N/A | $0 | |
| Aug 11, 2023 | James King Andrew | Executive | Disposition | 19,157 | $N/A | $0 | |
| Aug 11, 2023 | Krishnan Mahesh | Executive | Disposition | 1,275 | $N/A | $0 | |
| Aug 11, 2023 | Thomas Dolca | Executive | Disposition | 13,300 | $N/A | $0 | |
| Aug 1, 2023 | James King Andrew | Executive | Sale | 1,168 | $39.03 | $45.6K |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Sale(S) | 54 | $76.7M | 72.9% |
Purchase(P) | 17 | $28.1M | 26.7% |
Payment(F) | 4 | $257.9K | 0.2% |
Exercise(M) | 50 | $131.0K | 0.1% |
Disposition(D) | 14 | $0 | 0.0% |
Other(J) | 35 | $0 | 0.0% |
Gift(G) | 1 | $0 | 0.0% |
Award(A) | 7 | $0 | 0.0% |
Insider selling pressure at CHINOOK THERAPEUTICS, INC. has increased, with 14 insiders executing 182 transactions across all time. Total sales of $76.7M significantly outpace purchases of $28.1M, resulting in a net outflow of $48.6M. This selling activity appears largely discretionary, which may warrant closer attention from investors.